CDKN2A and glioblastoma: In addition, senescent cells were identified in resected glioblastoma multiforme (GBM) tissues from patients and in mouse GBM models, discovering that partially removing p16INK4a-positive malignant senescent cells modulates the tumor microenvironment and improves survival outcomes in GBM mice (Salam et al., 2023).